Skip to main content
7174 search results for:

AL Amyloidosis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 05-04-2024 | Cardiac Amyloidosis | Online First

    Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis

    Cardiac amyloidosis is a refractory cardiomyopathy with a poor prognosis and lacks effective treatments. N-terminal pro-brain natriuretic peptide (NT-proBNP) and troponin T are poor prognostic factors for myocardial amyloidosis. However, NT-proBNP …

  2. Open Access 01-12-2024 | Alzheimer's Disease | Letter

    Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

    Environmental and lifestyle factors can promote peripheral inflammation, contributing to later cognitive decline [ 5 – 9 ]. Infections, even occurring years before dementia onset, elevate dementia risk through peripheral inflammatory and vascular …

  3. 17-04-2024 | Amyloidosis | Online First

    ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review

    Leukocyte chemotactic factor-2 amyloidosis (ALECT2) is a recently described subtype of amyloidosis. IgG4-related disease is a rare fibroinflammatory condition characterized by dense interstitial lymphoplasmacytic infiltrates and fibrosis.

  4. 25-01-2024 | Amyloidosis | OriginalPaper

    A case of intestinal intussusception with unique hemorrhagic polyps due to AL amyloidosis and excessive anticoagulation

    Most adult intussusceptions are secondary to various pathological conditions that serve as a lead point. Because of their serious nature, intussusceptions often require emergency surgery. We report a surgical case of amyloidosis associated with …

  5. Open Access 01-12-2024 | Respiratory Microbiota | OriginalPaper

    Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner

    It has recently become well-established that there is a connection between Alzheimer’s disease pathology and gut microbiome dysbiosis. We have previously demonstrated that antibiotic-mediated gut microbiota perturbations lead to attenuation of Aβ …

  6. 22-01-2024 | AL Amyloidosis | Online First

    Silver-positive kidney AL amyloidosis

  7. 04-11-2023 | Amyloidosis | OriginalPaper

    Systemic AL amyloidosis with multiple submucosal hematomas of the colon: a case report and literature review

    Amyloid light-chain (AL) amyloidosis rarely causes colorectal submucosal hematoma. A 76-year-old man presented with a complaint of bloody stool. An initial colonoscopy revealed ulcerative lesions in the descending colon, leading to a diagnosis of …

  8. 22-07-2023 | COVID-19 Vaccination | OriginalPaper

    COVID-19 Vaccine Uptake in Patients with Multiple Myeloma and AL Amyloidosis: A Cross-Sectional Observational Study from India

    COVID-19 vaccine uptake has been comparable, if not higher, in LMICs (Low- and Middle-Income Countries) than in developed nations. Patients with plasma cell disorders are at a higher risk for developing COVID-19 related morbidity and mortality due …

  9. 08-08-2023 | Cardiac Amyloidosis | OriginalPaper

    Late gadolinium enhanced cardiac MR derived radiomics approach for predicting all-cause mortality in cardiac amyloidosis: a multicenter study

    Cardiac amyloidosis (CA) is caused by the accumulation of amyloid fibrils in cardiac tissue, which induces diastolic dysfunction [ 1 – 3 ]. Immunoglobulin light chain (AL) amyloidosis is the most common type of CA [ 4 ]. Up to 50% of patients with …

  10. Open Access 01-12-2023 | Alzheimer's Disease | OriginalPaper

    Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis

    Alzheimer’s disease (AD) is an incurable neurodegenerative disorder, clinically identifiable by a gradual cognitive decline, eventually leading to dementia and death [ 1 , 2 ]. AD is primarily characterised by the accumulation of abnormal protein …

  11. Open Access 02-09-2023 | AL Amyloidosis | ReviewPaper

    Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group

    Systemic immunoglobulin light chain (AL) amyloidosis is a heterogeneous rare disease driven by a destructive monoclonal gammopathy and typified by misfolded immunoglobulin light and/or heavy chains which aggregate and deposit in organs as …

  12. 03-08-2023 | AL Amyloidosis | Report

    Coinciding kappa AL amyloidosis and kappa light chain deposition disease in the lung

    Amyloid is primarily composed of insoluble extracellular fibrillar protein aggregates arranged in anti-parallel beta pleated sheet secondary structures that appear as amorphous, eosinophilic extracellular deposits when stained with hematoxylin and …

  13. 01-02-2023 | Daratumumab | ReviewPaper

    Diagnosis and Treatment of AL Amyloidosis

    Systemic light chain (AL) amyloidosis is caused by an usually small B cell clone that produces a toxic light chain forming amyloid deposits in tissue. The heart and kidney are the major organs affected, but all others, with the exception of the …

  14. 22-04-2023 | Alopecia | Report

    An unusual case of AL amyloidosis presenting as alopecia and nail changes

  15. Open Access 02-03-2023 | Daratumumab | OriginalPaper

    Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA

    Subcutaneous daratumumab plus bortezomib/cyclophosphamide/dexamethasone (VCd; D-VCd) improved outcomes versus VCd for patients with newly diagnosed immunoglobulin light-chain (AL) amyloidosis in the phase 3 ANDROMEDA study. We report a subgroup …

  16. Open Access 01-12-2022 | Alzheimer's Disease | OriginalPaper

    Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

    Cerebrospinal fluid (CSF) biomarkers play an important role in diagnosing Alzheimer’s disease (AD) which is characterized by amyloid-β (Aβ) amyloidosis. Here, we used two App knock-in mouse models, AppNL-F/NL-F and AppNL-G-F/NL-G-F, exhibiting …

  17. Open Access 01-12-2023 | Cardiomyopathy | OriginalPaper

    Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study

    Transthyretin amyloid cardiomyopathy (ATTR-CM) is caused by the accumulation of misfolded transthyretin fibrils in the myocardium which leads to heart failure [ 1 , 2 ]. ATTR-CM is a progressive and life-threatening disease. There are two types of …

  18. Open Access 01-12-2023 | Amyloidosis | Erratum

    Retraction Note: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis

    This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13195-021-00769-9.

  19. 30-05-2022 | Daratumumab | ReviewPaper

    Immunotherapy in AL Amyloidosis

    Light-chain amyloidosis is a rare disorder where a small clone of plasma cells is producing excess toxic light chains that deposit in various organs and cause dysfunction. Cardiac involvement is a major determinant of survival and rapid reduction …

  20. Open Access 01-12-2022 | Hyperparathyroidism | OriginalPaper

    Evaluation of multinodular goiter and primary hyperparathyroidism leads to a diagnosis of AL amyloidosis

    Amyloidosis is a heterogenous group of diseases in which extracellular deposits of insoluble beta pleated proteins known as amyloid build up in vital organs, commonly the heart, kidneys, and liver [ 1 ]. The most common cause of an amyloid disorder …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.